Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.51 - $0.93 $8,156 - $14,874
-15,994 Closed
0 $0
Q1 2022

Jun 30, 2022

SELL
$0.84 - $1.71 $1,031 - $2,099
-1,228 Reduced 7.13%
15,994 $13,000
Q4 2021

Feb 15, 2022

BUY
$1.59 - $2.38 $3,499 - $5,238
2,201 Added 14.65%
17,222 $28,000
Q3 2021

Oct 29, 2021

BUY
$1.69 - $2.89 $1,189 - $2,034
704 Added 4.92%
15,021 $36,000
Q2 2021

Aug 16, 2021

BUY
$2.64 - $6.32 $37,796 - $90,483
14,317 New
14,317 $38,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0

About SEELOS THERAPEUTICS, INC.


  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $109M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.